These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8557929)

  • 1. A delayed answer to the calcium blocker question.
    Parmley WW
    J Am Coll Cardiol; 1996 Feb; 27(2):510-1. PubMed ID: 8557929
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial infarction associated with antihypertensive drug therapy.
    Blandino DA
    JAMA; 1996 Feb; 275(7):516; author reply 517. PubMed ID: 8606468
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium channel blockers and myocardial infarction.
    Smith GN
    J Fam Pract; 1996 Jan; 42(1):30-2. PubMed ID: 8537801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium channel blockers scare].
    Zimlichman R
    Harefuah; 1997 Feb; 132(3):223-5. PubMed ID: 9154732
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial infarction associated with antihypertensive drug therapy.
    Cooper RS; Freeman V
    JAMA; 1996 Feb; 275(7):515-6; author reply 516-7. PubMed ID: 8606467
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested.
    Buring JE; Glynn RJ; Hennekens CH
    JAMA; 1995 Aug 23-30; 274(8):654-5. PubMed ID: 7637148
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the safety of felodipine based on clinical trials in patients with hypertension.
    Welin L; Elvelin L; Niklasson A; Olsson G; Elmfeldt D
    Am J Cardiol; 1997 Apr; 79(7):996-9. PubMed ID: 9104926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the LSMS Committee on Chronic Diseases. Recent media reports of potential risks from calcium antagonists.
    Frohlich ED
    J La State Med Soc; 1995 Aug; 147(8):343. PubMed ID: 7673778
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.
    Alderman M; Madhavan S; Cohen H
    Lancet; 1998 Jan; 351(9097):216-7. PubMed ID: 9449897
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics.
    Anderson RJ; Alabi RA; Kelly WN; Diseker R; Roblin D
    J Manag Care Pharm; 2003; 9(1):29-35. PubMed ID: 14613359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers and hypertension: 2. Safety issues.
    Epstein M
    Hosp Pract (1995); 1996 Dec; 31(12):93-6, 99-104. PubMed ID: 8969683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blocker.
    Li CJ; Shi ZD
    Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial infarction associated with antihypertensive drug therapy.
    Feeman WE
    JAMA; 1996 Feb; 275(7):515; author reply 516-7. PubMed ID: 8606466
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers. Consensus amid controversy.
    Kochar MS; Qurashi MI
    Postgrad Med; 1997 Dec; 102(6):127-8, 133-6. PubMed ID: 9406569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves i.v. calcium-channel blocker.
    Thompson CA
    Am J Health Syst Pharm; 2008 Sep; 65(18):1686. PubMed ID: 18768991
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium channel blocker use and gastrointestinal tract bleeding among older adults.
    Kaplan RC; Heckbert SR; Koepsell TD; Rosendaal FR; Furberg CD; Cooper LS; Psaty BM;
    Age Ageing; 2002 May; 31(3):217-8. PubMed ID: 12006312
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium-channel blockers and risk of myocardial infarction--more hype than harm.
    Phillips BG; MacFarlane LL; Carson DS
    Am J Health Syst Pharm; 1995 Jul; 52(13):1460-2. PubMed ID: 7671045
    [No Abstract]   [Full Text] [Related]  

  • 19. Study poses new questions about calcium-channel blockers.
    Jeffers ER
    Am J Health Syst Pharm; 1998 Apr; 55(8):762. PubMed ID: 9568234
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium antagonists should continue to be used for first-line treatment of hypertension.
    Epstein M
    Arch Intern Med; 1995 Nov; 155(20):2150-6. PubMed ID: 7487236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.